PROVECTUS BIOPHARMACEUTICALS, INC.: 10-Q filed 2019-11-12
What PROVECTUS BIOPHARMACEUTICALS, INC. reported in its quarterly report filed 2019-11-12 (fiscal Q3 2019): 27 published measures, 72 facts as tagged in accession 0001493152-19-016870.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-12
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001493152-19-016870 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PROVECTUS BIOPHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,563,957 | USD | |
| At 2018-12-31 | 1,988,224 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 24,152,077 | USD | |
| At 2018-12-31 | 19,405,713 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -22,588,120 | USD | |
| At 2019-06-30 | -20,965,092 | USD | |
| At 2019-03-31 | -18,804,352 | USD | |
| At 2018-12-31 | -17,417,489 | USD | |
| At 2018-09-30 | -15,288,607 | USD | |
| At 2018-06-30 | -13,700,390 | USD | |
| At 2018-03-31 | -12,495,960 | USD | |
| At 2017-12-31 | -10,018,843 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 434,787 | USD | |
| At 2018-12-31 | 50,986 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -1,820,075 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -5,367,224 | USD | 273 |
| 2019-04-01 to 2019-06-30 | -2,177,319 | USD | 91 |
| 2019-01-01 to 2019-03-31 | -1,369,830 | USD | 90 |
| 2018-07-01 to 2018-09-30 | -1,609,003 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -5,964,823 | USD | 273 |
| 2018-04-01 to 2018-06-30 | -1,456,208 | USD | 91 |
| 2018-01-01 to 2018-03-31 | -2,899,612 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -5,051,052 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -4,394,643 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 5,459,654 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 4,521,059 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -232,261,515 | USD | |
| At 2018-12-31 | -226,894,291 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 61,907 | USD | |
| At 2018-12-31 | 72,476 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 21,740 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 80,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -1,442,813 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -5,078,784 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -1,357,761 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -6,151,950 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 893,976 | USD | |
| At 2018-12-31 | 1,016,521 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 377,576 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,068,600 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 256,173 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 697,214 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 2,371,527 | USD | |
| At 2018-12-31 | 4,102,407 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 395,887 | USD | |
| At 2018-12-31 | 899,227 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,442,813 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 5,078,784 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 1,357,761 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 6,151,950 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,004,454 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 3,250,109 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 528,355 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 3,458,657 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 388,576,975 | shares | |
| At 2018-12-31 | 384,614,528 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 209,309,619 | USD | |
| At 2018-12-31 | 209,092,187 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -24,801 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 212,187 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 225,067 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 61,107 | USD | |
| At 2018-12-31 | 50,538 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 438,359 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 1,828,675 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 829,406 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 2,693,293 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 63,492 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 10,570 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 503,340 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 503,340 | USD | 273 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 66,952 | USD | 273 |
Inspect the source
- Entity
- PROVECTUS BIOPHARMACEUTICALS, INC. / CIK 0000315545
- Captured
- 2026-09-19T14:56:22.911Z
- SEC response SHA-256
5c46f06a9f23badc21fb49ef63f53fb89ac39f7570babcbf8a64cddf67fb05d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000315545.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))